WALTHAM, Mass. - Morphic Therapeutic (NASDAQ:MORF), a biopharmaceutical company, announced Monday the appointment of Simon Cooper, M.B.B.S., as its new Chief Medical Officer. Dr. Cooper, recognized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback